Research Insights section focuses on the cutting-edge and breakthrough research that is happening all over the world. Laboratories across the globe are working hard to develop drugs and therapies for various diseases and research insights directly from them add tremendous value.
Pancreatic ductal adenocarcinoma PDAC which constitutes of pancreatic cancer PC is the fourth most prevalent cause of cancerrelated mortality globally A study suggests that by the number of deaths in the US from PC will surpass that from breast
Sequencing data are ubiquitous in modern biology For example RNAseq data have been used to identify genes associated with clinical outcomes of cancer patients
Cell competition CC is a biological mechanism highly conserved from Drosophila to vertebrates and results in the elimination of less fit cells by their more fit neighbors
The Coronavirus Disease COVID caused by the SARSCoV virus emerged in late and rapidly evolved into a global pandemic impacting healthcare systems and economies worldwide
Traumatic brain injury results in hospitalizations and deaths in the US each year annually While there have been multiple TBI clinical treatment trials todate none have been successful One major challenge
Fracture nonunions affect many patients leading to functional and psychosocial disability Several risk factors have been described and include biological surgical and mechanical factors However none of them are able to determine
There has been significant concern regarding the spread of SARSCoV on transportation systems The earliest superspreading events were associated with transportation on cruise ships Multiple incidents
COVID is an acute respiratory infection caused by the coronavirus SARSCoV characterized by high contagiousness and mortality of the infected population which determines its high socioeconomic significance
Alzheimer disease is a heterogeneous multifactorial neurodegenerative disorder pathologically characterized by amyloid plaques neurofibrillary tangles neuroinflammation and synaptic and neuronal loss
Individuals with certain malignancies organ transplant recipients and immunecompromised individuals could mount either an incomplete or suboptimal antibody response to primary series vaccination
